Patrick Vélicitat
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Inflammatory mediators and NSAID effects 2
- Drug-Induced Adverse Reactions 2
-
- Urinary Tract Infections Management 4
- Co-authors
- Erich Bluhmki (3 shared papers)R.-L. Dreiser (1 shared paper)Philipp Knechtle (3 shared papers)J. M. Le Parc (1 shared paper)Paola Motta (3 shared papers)Adam Belley (4 shared papers)Keith S. Kaye (2 shared papers)H. Zeidler (1 shared paper)
- Journals
- Inflammation Research (3 papers)Open Forum Infectious Diseases (3 papers)Antimicrobial Agents and Chemotherapy (1 paper)Clinical Therapeutics (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Patrick Vélicitat
11 papers receiving 320 citations
Peers
Comparison fields: 5 of 67
- Applied Microbiology and Biotechnology 31
- Molecular Medicine 61
- Pharmacology 134
- Rheumatology 82
- Anatomy 3
Countries citing papers authored by Patrick Vélicitat
This map shows the geographic impact of Patrick Vélicitat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Vélicitat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Vélicitat more than expected).
Fields of papers citing papers by Patrick Vélicitat
This network shows the impact of papers produced by Patrick Vélicitat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Vélicitat. The network helps show where Patrick Vélicitat may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Vélicitat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 72 | |
| 2 | Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. | 1999 | 66 |
| 3 | 2001 | 47 | |
| 4 | 2001 | 32 | |
| 5 | 2020 | 29 | |
| 6 | 1995 | 24 | |
| 7 | 2000 | 23 | |
| 8 | 1996 | 21 | |
| 9 | 2000 | 18 | |
| 10 | 2001 | 16 | |
| 11 | 2020 | 2 | |
| 12 | 2021 | 0 | |
| 13 | 2023 | 0 | |
| 14 | 2004 | 0 |
About Patrick Vélicitat
Patrick Vélicitat is a scholar working on Pharmacology, Epidemiology, Rheumatology, Pulmonary and Respiratory Medicine and Molecular Medicine, having authored 14 papers that have together received 350 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Urinary Tract Infections Management (4 papers), Inflammatory mediators and NSAID effects (2 papers), Drug-Induced Adverse Reactions (2 papers), Intramuscular injections and effects (2 papers), Antibiotic Resistance in Bacteria (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and Renal Transplantation Outcomes and Treatments (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (31 citations), Molecular Medicine (61 citations), Pharmacology (134 citations), Rheumatology (82 citations) and Anatomy (3 citations). Patrick Vélicitat has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Erich Bluhmki, R.-L. Dreiser, Philipp Knechtle, J. M. Le Parc, Paola Motta, Adam Belley, Keith S. Kaye, H. Zeidler, Bernard Combe and Maxime Dougados. Their work appears in journals such as Inflammation Research, Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Clinical Therapeutics and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.